Keyphrases
Randomized Placebo-controlled Trial
100%
Fenfluramine
100%
Dravet Syndrome
100%
Convulsive Seizures
75%
Placebo
50%
Seizure Frequency
37%
Phase III Clinical Trial
25%
Confidence Interval
12%
Randomized Double-blind
12%
Placebo-controlled
12%
Baseline Period
12%
Maximum Tolerated Dose
12%
Pyrexia
12%
Valvular Heart Disease
12%
Decreased Appetite
12%
Somnolence
12%
Blood Glucose
12%
Titration
12%
Maintenance Interval
12%
Antiseizure
12%
Medicine and Dentistry
Placebo
100%
Controlled Clinical Trial
100%
Severe Myoclonic Epilepsy of Infancy
100%
Fenfluramine
100%
Epileptic Seizure
75%
Clinical Trial
25%
Blood Glucose
12%
Valvular Heart Disease
12%
Somnolence
12%
Pulmonary Hypertension
12%
Decreased Appetite
12%
Titrimetry
12%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Controlled Clinical Trial
100%
Fenfluramine
100%
Severe Myoclonic Epilepsy in Infancy
100%
Clinical Trial
25%
Decreased Appetite
12%
Pulmonary Hypertension
12%
Somnolence
12%
Valvular Heart Disease
12%
Stiripentol
12%